Clear.bio closed a funding round (amount undisclosed) in Nov 2022. The company is based in Amsterdam, Netherlands. Investors in the round: Achmea Innovation Fund. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
